Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
8.02
+0.25 (3.22%)
At close: Mar 9, 2026, 4:00 PM EDT
8.02
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:10 PM EDT
Journey Medical Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 267 | 82 | 107 | 34 | 90 | - | |
| Market Cap Growth | 148.40% | -23.38% | 212.54% | -61.94% | - | - | |
| Enterprise Value | 258 | 80 | 85 | 25 | 109 | - | |
| Last Close Price | 7.77 | 3.91 | 5.76 | 1.92 | 5.38 | - | |
| PS Ratio | 4.34 | 1.46 | 1.35 | 0.46 | 1.42 | - | |
| PB Ratio | 7.91 | 4.07 | 5.24 | 2.01 | 2.13 | - | |
| P/TBV Ratio | - | - | 1692.20 | - | 3.04 | - | |
| P/FCF Ratio | - | - | 20.35 | - | - | - | |
| P/OCF Ratio | - | - | 20.35 | - | - | - | |
| EV/Sales Ratio | 4.35 | 1.43 | 1.07 | 0.33 | 1.73 | - | |
| EV/EBITDA Ratio | - | - | 17.57 | - | - | - | |
| EV/EBIT Ratio | - | - | 79.43 | - | - | - | |
| EV/FCF Ratio | - | - | 16.22 | - | - | - | |
| Debt / Equity Ratio | 0.98 | 1.28 | 0.87 | 1.57 | 0.22 | 1.76 | |
| Debt / EBITDA Ratio | - | - | 3.59 | - | - | 1.93 | |
| Debt / FCF Ratio | - | - | 3.38 | - | - | 3.52 | |
| Net Debt / Equity Ratio | 0.01 | 0.27 | -0.48 | -0.32 | -0.95 | 0.95 | |
| Net Debt / EBITDA Ratio | -0.27 | -0.53 | -2.01 | 0.23 | 2.45 | 1.06 | |
| Net Debt / FCF Ratio | -0.09 | -0.59 | -1.85 | 0.40 | 18.36 | 1.91 | |
| Asset Turnover | 0.80 | 0.72 | 0.87 | 0.73 | 0.85 | 1.04 | |
| Inventory Turnover | 1.71 | 1.70 | 1.88 | 2.56 | 4.54 | 12.91 | |
| Quick Ratio | 1.08 | 0.87 | 1.02 | 0.90 | 1.40 | 1.15 | |
| Current Ratio | 1.42 | 1.37 | 1.35 | 1.16 | 1.64 | 1.26 | |
| Return on Equity (ROE) | -47.05% | -72.60% | -20.64% | -100.39% | -168.12% | 81.00% | |
| Return on Assets (ROA) | -4.60% | -10.88% | 0.73% | -16.99% | -15.79% | 11.44% | |
| Return on Invested Capital (ROIC) | -21.77% | -75.75% | 9.62% | -404.39% | -170.38% | 40.91% | |
| Return on Capital Employed (ROCE) | -12.10% | -30.30% | 3.10% | -71.80% | -41.30% | 32.90% | |
| Earnings Yield | -3.36% | -17.96% | -3.61% | -86.86% | -49.09% | - | |
| FCF Yield | -1.53% | -11.17% | 4.92% | -39.68% | -2.43% | - | |
| Buyback Yield / Dilution | -16.55% | -12.06% | -4.00% | -72.05% | 5.96% | -7.55% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.